Advanced search
Publication Cover
Emerging Microbes & Infections Volume 11, 2022 - Issue 1
Submit an article Journal homepage
4,945
Views
44
CrossRef citations to date
0
Altmetric
Coronaviruses

Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study

Paskorn Sritipsukhoa Center of Excellence in Applied Epidemiology, Thammasat University, Pathumthani, Thailand;b Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, ThailandView further author information
,
Thana Khawcharoenporna Center of Excellence in Applied Epidemiology, Thammasat University, Pathumthani, Thailand;c Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani, ThailandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6093-2887View further author information
ORCID Icon,
Boonying Siribumrungwonga Center of Excellence in Applied Epidemiology, Thammasat University, Pathumthani, Thailand;d Department of Surgery, Faculty of Medicine, Thammasat University, Pathumthani, ThailandView further author information
,
Pansachee Damronglerdc Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani, ThailandView further author information
,
Nuntra Suwantarate Department of Internal Medicine, Chulabhorn International College of Medicine, Thammasat University, Pathumthani, ThailandView further author information
,
Araya Satdhabudhab Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, ThailandView further author information
,
Chanapai Chaiyakulsilb Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, ThailandView further author information
,
Phakatip Sinlapamongkolkulb Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, ThailandORCID Iconhttps://orcid.org/0000-0001-9602-4768View further author information
ORCID Icon,
Auchara Tangsathapornpongb Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, ThailandView further author information
,
Pornumpa Bunjoungmaneeb Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, ThailandView further author information
,
Sira Nanthapisala Center of Excellence in Applied Epidemiology, Thammasat University, Pathumthani, Thailand;b Department of Pediatrics, Faculty of Medicine, Thammasat University, Pathumthani, ThailandView further author information
,
Chamnan Tanprasertkula Center of Excellence in Applied Epidemiology, Thammasat University, Pathumthani, Thailand;f Department of Obstetrics & Gynecology, Faculty of Medicine, Thammasat University, Pathumthani, ThailandView further author information
,
Naiyana Sritipsukhog Thammasat University, Pathumthani, ThailandView further author information
,
Chatchai Mingmalairakd Department of Surgery, Faculty of Medicine, Thammasat University, Pathumthani, ThailandView further author information
,
Anucha Apisarnthanaraka Center of Excellence in Applied Epidemiology, Thammasat University, Pathumthani, Thailand;c Division of Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Thammasat University, Pathumthani, ThailandView further author information
&
Pichaya Tantiyavarongh Department of Clinical Epidemiology, Faculty of Medicine, Thammasat University, Pathumthani, ThailandView further author information
 show all
Pages 585-592 | Received 23 Dec 2021, Accepted 29 Jan 2022, Published online: 16 Feb 2022

Citations (44)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Paskorn Sritipsukho, Thana Khawcharoenporn, Boonying Siribumrungwong, Pansachee Damronglerd, Nuntra Suwantarat, Araya Satdhabudha, Chanapai Chaiyakulsil, Phakatip Sinlapamongkolkul, Auchara Tangsathapornpong, Pornumpa Bunjoungmanee, Sira Nanthapisal, Chamnan Tanprasertkul, Naiyana Sritipsukho, Chatchai Mingmalairak, Anucha Apisarnthanarak & Pichaya Tantiyavarong. (2023) Real-life effectiveness of COVID-19 vaccine during the Omicron variant-dominant pandemic: how many booster doses do we need?. Emerging Microbes & Infections 12:1.
Read now
Thachanun Porntharukchareon, Wipada Chartisathian, Manassamon Navinpipat, Chayanee Samdaengpan, Kunsuda Cheirsilpa, Aimwipa Lueprasitsakul, Supanat Worawichawong, Viroj Muangsillapasart, Pratya Pumuthaivirat, Bothamai Dechates, Supamas Sirisreetreerux, Taweegrit Siripongboonsitti, Vimonsri Rangsrisaeneepitak, Kerati Jirawattanapalin & Kriangkrai Tawinprai. (2023) The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study. Human Vaccines & Immunotherapeutics 19:2.
Read now
Chenchit Chayachinda, Kanokwaroon Watananirun, Chayawat Phatihattakorn, Sanitra Anuwutnavin, Suvimol Niyomnaitham, Wanatpreeya Phongsamart, Keswadee Lapphra, Orasri Wittawatmongkol, Supattra Rungmaitree, Laddawan Jansarikit, Kobporn Boonnak, Patimaporn Wongprompitak, Sansnee Senawong, Avishek Upadhya, Zheng Quan Toh, Paul V. Licciardi & Kulkanya Chokephaibulkit. (2023) Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women. Human Vaccines & Immunotherapeutics 19:2.
Read now
Xiaoyin Zhang, Jiayue Xia, Lairun Jin, Yanfei Wu, Xiuyu Zheng, Xiang Cao, Xingchen Meng, Jingxin Li & Fengcai Zhu. (2023) Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis. Human Vaccines & Immunotherapeutics 19:2.
Read now
Moe H. Kyaw, Julia Spinardi, Ling Zhang, Helen May Lin Oh & Amit Srivastava. (2023) Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines. Human Vaccines & Immunotherapeutics 19:1.
Read now
Suvimol Niyomnaitham, Zheng Quan Toh, Patimaporn Wongprompitak, Laddawan Jansarikit, Kanjana Srisutthisamphan, Sompong Sapsutthipas, Yuparat Jantraphakorn, Natthakarn Mingngamsup, Paul V Licciardi & Kulkanya Chokephaibulkit. (2022) Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults. Human Vaccines & Immunotherapeutics 18:6.
Read now
Rontgene Solante, Carlos Alvarez-Moreno, Erlina Burhan, Suwat Chariyalertsak, Nan-Chang Chiu, Sunate Chuenkitmongkol, Dung Do-Van, Kao-Pin Hwang, Sasisopin Kiertiburanakul, Ping-Ing Lee, Rommel Crisenio Lobo, Alejandro Macias, Cao Huu Nghia, Anna Ong-Lim, Javier Ortiz Ibarra, Rosana Richtmann, Alfonso J. Rodriguez-Morales, Marco Aurélio P Safadi & Hindra Irawan Satari. (2022) Further implications on the global real-world vaccine effectiveness against SARS-CoV-2. Expert Review of Vaccines 21:9, pages 1355-1357.
Read now
Sunate Chuenkitmongkol, Rontgene Solante, Erlina Burhan, Suwat Chariyalertsak, Nan-Chang Chiu, Dung Do-Van, Masliyana Husin, Kao-Pin Hwang, Sasisopin Kiertiburanakul, Prasad S. Kulkarni, Ping-Ing Lee, Rommel Crisenio Lobo, Cao Huu Nghia, Anna Ong-Lim, Sheamini Sivasampu, Jing Lian Suah, Peter Seah Keng Tok & Guy Thwaites. (2022) Expert review on global real-world vaccine effectiveness against SARS-CoV-2. Expert Review of Vaccines 21:9, pages 1255-1268.
Read now

Articles from other publishers (36)

Giovanni Corrao, Gloria Porcu, Alina Tratsevich, Danilo Cereda, Giovanni Pavesi, Guido Bertolaso & Matteo Franchi. (2024) Estimating All-Cause Deaths Averted in the First Two Years of the COVID-19 Vaccination Campaign in Italy. Vaccines 12:4, pages 413.
Crossref
Juan C. Alzate-Ángel, Paula A. Avilés-Vergara, David Arango-Londoño, Alberto Concha-Eastman, Anthony Garcés-Hurtado, Liliana López-Carvajal, Ingrid L. Minotta, Delia Ortega-Lenis, Geraldine Quintero, Sebastián Reina-Bolaños, Carlos A. Reina-Bolaños, Pablo Roa, Melanie Sánchez-Orozco, Catalina Tovar-Acero & María P. Arbeláez-Montoya. (2024) How has research on the effectiveness and safety of COVID-19 vaccination been evaluated: a scope review with emphasis on CoronaVac. Frontiers in Public Health 12.
Crossref
Thana Khawcharoenporn & Sirashat Hanvivattanakul. (2023) Safety profiles of homologous and heterologous regimens containing three major types of COVID-19 vaccine among people living with HIV. International Journal of STD & AIDS 35:4, pages 262-273.
Crossref
Lia Reynolds, Cate Dewey, Ghaid Asfour & Matthew Little. (2023) Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review. Frontiers in Public Health 11.
Crossref
Mark A. Katz, Madelyn Yiseth Rojas Castro, Nabil Seyidov, M. Trent Herdman, Samir Mehdiyev, C. Jason McKnight, Alina Guseinova, Radu Cojocaru, Jason Doran, Barbara Mühlemann, Christian Drosten, Javahir Suleymanova, Richard Pebody, Esther Kissling & Gahraman Hagverdiyev. (2023) The effectiveness of primary series CoronaVac vaccine in preventing COVID‐19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May–November 2021. Influenza and Other Respiratory Viruses 17:10.
Crossref
Orasri Wittawatmongkol, Pornumpa Bunjoungmanee, Pope Kosalaraksa, Kamolwish Laoprasopwattana, Sophida Boonsathorn, Napaporn Chantasrisawad, Tavitiya Sudjaritruk, Suvimol Niyomnaitham, Sansnee Senawong, Kanjana Srisutthisamphan, Zheng Quan Toh, Supattra Rungmaitree, Sira Nanthapisal, Supranee Phanthanawiboon, Puttichart Khantee, Chonnamet Techasaensiri, Nattiya Hirankarn, Sipang Pangprasertkul & Kulkanya Chokephaibulkit. (2023) Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5–11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial. Vaccine 41:40, pages 5834-5840.
Crossref
Martin Law, Sam S.H. Ho, Gigi K.C. Tsang, Clarissa M.Y. Ho, Christine M. Kwan, Vincent Ka Chun Yan, Hei Hang Edmund Yiu, Francisco Tsz Tsun Lai, Ian Chi Kei Wong & Esther Wai Yin Chan. (2023) Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis. The Lancet Regional Health - Western Pacific 37, pages 100788.
Crossref
John D Hart, Darren Suryawijaya Ong, Kulkanya Chokephaibulkit, Anna T Ong-Lim, Ilisapeci Vereti, Nigel W Crawford & Fiona Russell. (2023) Considerations for vaccinating children against COVID-19. BMJ Paediatrics Open 7:1, pages e001964.
Crossref
Unab Inayat Khan, Mahnoor Niaz, Iqbal Azam, Zahra Hasan, Imran Hassan, Syed Faisal Mahmood & Asad Ali. (2023) Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 infections among healthcare personnel in Pakistan: a test-negative case–control study. BMJ Open 13:6, pages e071789.
Crossref
Thanus Pienthong, Watcharee Chancharoenrat, Sirinporn Sajak, Suphannee Phetsaen, Padcharadda Hanchai, Kanokporn Thongphubeth & Thana Khawcharoenporn. (2023) Risk categorization and outcomes among healthcare workers exposed to COVID-19: A cohort study from a Thai tertiary-care center. Journal of Microbiology, Immunology and Infection 56:3, pages 537-546.
Crossref
Chanapai Chaiyakulsil, Paskorn Sritipsukho, Araya Satdhabudha, Pornumpa Bunjoungmanee, Auchara Tangsathapornpong, Phakatip Sinlapamongkolkul & Naiyana Sritipsukho. (2023) Prevalence, risk factors, and vaccine effectiveness of COVID-19 infection in thai children, adolescents, and young adults in the omicron era. Frontiers in Pediatrics 11.
Crossref
Paulina Kaplonek, Yixiang Deng, Jessica Shih-Lu Lee, Heather J. Zar, Dace Zavadska, Marina Johnson, Douglas A. Lauffenburger, David Goldblatt & Galit Alter. (2023) Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines. Cell Reports Medicine 4:5, pages 101048.
Crossref
Shiyao Xu, Jincheng Li, Hongyuan Wang, Fuzhen Wang, Zundong Yin & Zhifeng Wang. (2023) Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis. BMC Medicine 21:1.
Crossref
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli & Soliman Mohammadi-Samani. (2023) Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2. International Immunopharmacology 117, pages 109968.
Crossref
Catharina Gerhards, Margot Thiaucourt, Michael Hetjens, Verena Haselmann, Michael Neumaier & Maximilian Kittel. (2023) Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines. Vaccines 11:3, pages 701.
Crossref
Kannikar Intawong, Suwat Chariyalertsak, Kittipan Chalom, Thanachol Wonghirundecha, Woravut Kowatcharakul, Aksara Thongprachum, Narain Chotirosniramit, Worachet Teacharak, Pimpinan khammawan, Jarurin Waneesorn & Sopon Iamsirithaworn. (2023) Effectiveness of heterologous third and fourth dose COVID-19 vaccine schedules for SARS-CoV-2 infection during delta and omicron predominance in Thailand: a test-negative, case-control study. The Lancet Regional Health - Southeast Asia 10, pages 100121.
Crossref
Shengyu Wu, Luyao Wang, Jiaqi Dong, Yirong Bao, Xiaohui Liu, Yuhong Li, Xiaohua Liu, Han Xie & Hao Ying. (2023) The dose- and time-dependent effectiveness and safety associated with COVID-19 vaccination during pregnancy: a systematic review and meta-analysis. International Journal of Infectious Diseases 128, pages 335-346.
Crossref
Nonthanat Tongsengkee, Smonrapat Surasombatpattana, Wiwatana Tanomkiat, Pisud Siripaitoon, Narongdet Kositpantawong, Siripen Kanchanasuwan, Asma Navasakulpong, Nawamin Pinpathomrat, Arunee Dechaphunkul, Atthaphong Phongphithakchai, Thanaporn Hortiwakul, Boonsri Charoenmak & Sarunyou Chusri. (2023) Characteristics, Outcomes, and Factors Affecting Mortality in Hospitalized Patients with CAP Due to Different Variants of SARS-CoV-2 and Non-COVID-19 CAP. Journal of Clinical Medicine 12:4, pages 1388.
Crossref
Thanyarat Promlek, Tonsan Hansirisathit, Jadsada Kunno & Maytawan Thanunchai. (2023) The Effects of CoronaVac and ChAdOx1 nCoV-19 in Reducing Severe Illness in Thailand: A Retrospective Cohort Study. Tropical Medicine and Infectious Disease 8:2, pages 95.
Crossref
Jiayue Wan, Casey L. Cazer, Marin E. Clarkberg, Shane G. Henderson, Scarlett E. Lee, Genevive R. Meredith, Marwan Osman, David B. Shmoys & Peter I. Frazier. (2023) Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study. PLOS Medicine 20:1, pages e1004153.
Crossref
AlaaY Ayed, NasirM Younis & MahmoudM Ahmed. (2023) Comparison of infection severity of vaccinated and unvaccinated health workers with Corona Virus: A cohort study. Journal of Education and Health Promotion 12:1, pages 336.
Crossref
Mingkwan Wichaidit, Tanawin Nopsopon, Krittiyaporn Sunan, Phanupong Phutrakool, Puripant Ruchikachorn, Dittaya Wanvarie, Ploy Naruemon Pratanwanich, Nontawit Cheewaruangroj, Proadpran Punyabukkana & Krit Pongpirul. (2023) Breakthrough infections, hospital admissions, and mortality after major COVID-19 vaccination profiles: a prospective cohort study. The Lancet Regional Health - Southeast Asia 8, pages 100106.
Crossref
Natthaprang Nittayasoot, Rapeepong Suphanchaimat, Panithee Thammawijaya, Chuleeporn Jiraphongsa, Taweesap Siraprapasiri, Kritchavat Ploddi, Chakkarat Pittayawonganon, Surakameth Mahasirimongkol & Piyanit Tharmaphornpilas. (2022) Real-World Effectiveness of COVID-19 Vaccines against Severe Outcomes during the Period of Omicron Predominance in Thailand: A Test-Negative Nationwide Case–Control Study. Vaccines 10:12, pages 2123.
Crossref
Baoqi Zeng, Le Gao, Qingxin Zhou, Kai Yu & Feng Sun. (2022) Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis. BMC Medicine 20:1.
Crossref
Ecem Bolat, Furkan Eker, Merve Kaplan, Hatice Duman, Ayşenur Arslan, Sümeyye Saritaş, Arif Sercan Şahutoğlu & Sercan Karav. (2022) Lactoferrin for COVID-19 prevention, treatment, and recovery. Frontiers in Nutrition 9.
Crossref
J. Fevery & K. Dallmeier. (2022) Immunologische aspecten van Covid-19-ziekte en van vaccinatie tegen SARS-CoV-2 Deel 2: Variaties van het immuunantwoord individueel en in de tijd bij een infectie met SARS-CoV-2 en bij vaccinatie. Tijdschrift voor Geneeskunde.
Crossref
Kavinthra Teerakathiti, Arin Jaisin, Phasittha Pongsapan, Nattapas Wanaporn, Phakhajee Rattanalertpaiboon, Supisa Chantanawanichwong, Sopittar Kittipavara, Supicha Sroythong, Nutchaphon Kanchan, Phasit Hongpromyati, Yotsakorn Chuaychoo, Raweeroj Uengpitugpun, Poopan Kiraniponpan, Witchakorn Trisukon, Mathirut Mungthin & Sakarn Charoensakulchai. (2022) DETERMINING STRESS AND ASSOCIATED FACTORS IN A RURAL COMMUNITY DURING COVID-19 PANDEMIC USING THE COVID STRESS SCALE. Journal of Southeast Asian Medical Research 6, pages e0133.
Crossref
Sue Ann Costa Clemens, Carlos Magno Castelo Branco Fortaleza, Madeleine Crowe, Karen Ingrid Tasca, André Gasparini Spadaro, Jayme Augusto Souza-Neto, Rejane Maria Tommasini Grotto, Regina Sider, Jose Jimeno, Thomas Verstraeten & Ralf Clemens. (2022) Effectiveness of the Fiocruz recombinant ChadOx1-nCoV19 against variants of SARS-CoV-2 in the Municipality of Botucatu-SP. Frontiers in Public Health 10.
Crossref
Kantarida Sripanidkulchai, Pinyo Rattanaumpawan, Winai Ratanasuwan, Nasikarn Angkasekwinai, Susan Assanasen, Peerawong Werarak, Oranich Navanukroh, Phatharajit Phatharodom & Teerapong Tocharoenchok. (2022) A Risk Prediction Model and Risk Score of SARS-CoV-2 Infection Following Healthcare-Related Exposure. Tropical Medicine and Infectious Disease 7:9, pages 248.
Crossref
Protim Sarker, Evana Akhtar, Rakib Ullah Kuddusi, Mohammed Mamun Alam, Md. Ahsanul Haq, Md. Biplob Hosen, Bikash Chandra Chanda, Farjana Haque, Muntasir Alam, Abdur Razzaque, Mustafizur Rahman, Faruque Ahmed, Md. Golam Kibria, Mohammed Zahirul Islam, Shehlina Ahmed & Rubhana Raqib. (2022) Comparison of the Immune Responses to COVID-19 Vaccines in Bangladeshi Population. Vaccines 10:9, pages 1498.
Crossref
Katharigatta N. Venugopala. (2022) Progress Update on the Epidemiology of COVID-19 Variants and the Assessment Status of Developed Vaccines. Journal of Pharmacology and Pharmacotherapeutics 13:3, pages 293-299.
Crossref
Xiaofeng He, Jiao Su, Yu’nan Ma, Wenping Zhang & Shixing Tang. (2022) A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines. Frontiers in Immunology 13.
Crossref
Yajuan Zhu, Shuang Liu & Dingmei Zhang. (2022) Effectiveness of COVID-19 Vaccine Booster Shot Compared with Non-Booster: A Meta-Analysis. Vaccines 10:9, pages 1396.
Crossref
Yaqun Fu, Jingyu Zhao, Xia Wei, Peien Han, Li Yang, Tao Ren, Siyan Zhan & Liming Li. (2022) Effectiveness and Cost-Effectiveness of Inactivated Vaccine to Address COVID-19 Pandemic in China: Evidence From Randomized Control Trials and Real-World Studies. Frontiers in Public Health 10.
Crossref
Cong Sun, Chu Xie, Guo-Long Bu, Lan-Yi Zhong & Mu-Sheng Zeng. (2022) Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants. Signal Transduction and Targeted Therapy 7:1.
Crossref
Xuemei Yan, Zhihui Dai, Qianhui Wu, Xiaolei Wang, Yan Wang, Ge Zeng, Yanpeng Wu, Shengbao Chen, Lan Yi, Hongjie Yu & Lidong Gao. (2022) Effectiveness of Inactivated SARS-CoV-2 Vaccines During a Delta Variant Outbreak in Hunan Province, China: A Retrospective Cohort Study. Zoonoses 2:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.